You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱萊英(002821.SZ):與與鎮江經開區管委會簽署小分子藥物綜合性研發生產基地項目投資協議 預計投資總額40-50億元
格隆匯 09-28 19:18

格隆匯 9 月 28日丨凱萊英(002821.SZ)公佈,為推動公司整體產業發展的戰略佈局,進一步提升公司創新藥研發生產全產業鏈服務能力,公司與鎮江經濟技術開發區管理委員會(以下簡稱“鎮江經開區管委會”)於2020年9月28日簽訂了《小分子藥物綜合性研發生產基地項目投資協議》(以下簡稱“投資協議”),公司擬以自有或自籌資金40-50億元人民幣在鎮江市投資小分子藥物綜合性研發生產基地。該事項已於2020年9月28日經公司第三屆董事會第四十六次會議審議通過,根據相關規定,該事項尚需公司股東大會審議通過後方生效,並進一步推進,故尚存在不確定性。本次簽署投資協議事項不構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。

項目預計投資總額40-50億元人民幣,項目規劃將整體設計、分期建設、分批投產。目前尚處於籌備階段,短期內不會對公司的財務狀況和經營成果造成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account